• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

果糖与食品防腐剂协同作用对代谢相关脂肪性肝病(MASLD)的影响:从肠道微生物组改变到肝脏基因表达。

Synergistic Effects of Fructose and Food Preservatives on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): From Gut Microbiome Alterations to Hepatic Gene Expression.

机构信息

Laboratory of Gnotobiology, Institute of Microbiology, Czech Academy of Sciences, 549 22 Novy Hradek, Czech Republic.

出版信息

Nutrients. 2024 Oct 30;16(21):3722. doi: 10.3390/nu16213722.

DOI:10.3390/nu16213722
PMID:39519554
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11547954/
Abstract

: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing global health problem closely linked to dietary habits, particularly high fructose consumption. This study investigates the combined effects of fructose and common food preservatives (sodium benzoate, sodium nitrite, and potassium sorbate) on the development and progression of MASLD. : We utilized a human microbiota-associated mouse model, administering 10% fructose with or without preservatives for 11 weeks. Liver histology, hepatic gene expression (microarray analysis), biochemical markers, cytokine profiles, intestinal permeability, and gut microbiome composition (16S rRNA and Internal Transcribed Spacer (ITS) sequencing) were evaluated. : Fructose and potassium sorbate synergistically induced liver pathology characterized by increased steatosis, inflammation and fibrosis. These histological changes were associated with elevated liver function markers and altered lipid profiles. The treatments also induced significant changes in both the bacterial and fungal communities and disrupted intestinal barrier function, leading to increased pro-inflammatory responses in the mesenteric lymph nodes. Liver gene expression analysis revealed a wide range of transcriptional changes induced by fructose and modulated by the preservative. Key genes involved in lipid metabolism, oxidative stress, and inflammatory responses were affected. : Our findings highlight the complex interactions between dietary components, gut microbiota, and host metabolism in the development of MASLD. The study identifies potential risks associated with the combined consumption of fructose and preservatives, particularly potassium sorbate. Our data reveal new mechanisms that are involved in the development of MASLD and open up a new avenue for the prevention and treatment of MASLD through dietary interventions and the modulation of the microbiome.

摘要

代谢相关脂肪性肝病(MAFLD)是一个日益严重的全球性健康问题,与饮食习惯密切相关,尤其是高果糖的摄入。本研究探讨了果糖和常见食品防腐剂(苯甲酸钠、亚硝酸钠和山梨酸钾)联合作用对 MAFLD 发展和进展的影响。

我们使用了一种人微生物群相关的小鼠模型,用 10%的果糖和/或防腐剂喂养 11 周。评估了肝脏组织学、肝基因表达(微阵列分析)、生化标志物、细胞因子谱、肠道通透性和肠道微生物群组成(16S rRNA 和内部转录间隔区(ITS)测序)。

果糖和山梨酸钾协同诱导肝脏病理改变,表现为脂肪变性、炎症和纤维化增加。这些组织学变化与肝功能标志物升高和脂质谱改变有关。这些处理还导致细菌和真菌群落的显著变化,并破坏了肠道屏障功能,导致肠系膜淋巴结中促炎反应增加。肝基因表达分析显示,果糖诱导的广泛转录变化受防腐剂的调节。涉及脂质代谢、氧化应激和炎症反应的关键基因受到影响。

我们的研究结果强调了饮食成分、肠道微生物群和宿主代谢在 MAFLD 发展中的复杂相互作用。该研究确定了与果糖和防腐剂联合摄入相关的潜在风险,特别是山梨酸钾。我们的数据揭示了新的机制,这些机制涉及 MAFLD 的发展,并为通过饮食干预和微生物组的调节预防和治疗 MAFLD 开辟了新的途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cbd/11547954/3cc6d918fb18/nutrients-16-03722-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cbd/11547954/21750a3408d6/nutrients-16-03722-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cbd/11547954/6e32eafcb928/nutrients-16-03722-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cbd/11547954/300b8d385c1d/nutrients-16-03722-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cbd/11547954/49c561b8016a/nutrients-16-03722-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cbd/11547954/31bca35cb893/nutrients-16-03722-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cbd/11547954/df6a743b8f01/nutrients-16-03722-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cbd/11547954/e592cdf7074c/nutrients-16-03722-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cbd/11547954/3cc6d918fb18/nutrients-16-03722-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cbd/11547954/21750a3408d6/nutrients-16-03722-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cbd/11547954/6e32eafcb928/nutrients-16-03722-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cbd/11547954/300b8d385c1d/nutrients-16-03722-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cbd/11547954/49c561b8016a/nutrients-16-03722-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cbd/11547954/31bca35cb893/nutrients-16-03722-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cbd/11547954/df6a743b8f01/nutrients-16-03722-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cbd/11547954/e592cdf7074c/nutrients-16-03722-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cbd/11547954/3cc6d918fb18/nutrients-16-03722-g008.jpg

相似文献

1
Synergistic Effects of Fructose and Food Preservatives on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): From Gut Microbiome Alterations to Hepatic Gene Expression.果糖与食品防腐剂协同作用对代谢相关脂肪性肝病(MASLD)的影响:从肠道微生物组改变到肝脏基因表达。
Nutrients. 2024 Oct 30;16(21):3722. doi: 10.3390/nu16213722.
2
Exploring the Regulatory Effect of LPJZ-658 on Copper Deficiency Combined with Sugar-Induced MASLD in Middle-Aged Mice Based on Multi-Omics Analysis.基于多组学分析探究 LPJZ-658 对中年铜缺乏合并糖诱导的 MASLD 的调控作用。
Nutrients. 2024 Jun 25;16(13):2010. doi: 10.3390/nu16132010.
3
Dietary copper-fructose interactions alter gut microbial activity in male rats.膳食铜-果糖相互作用改变雄性大鼠肠道微生物的活性。
Am J Physiol Gastrointest Liver Physiol. 2018 Jan 1;314(1):G119-G130. doi: 10.1152/ajpgi.00378.2016. Epub 2017 Oct 12.
4
Lupeol improves bile acid metabolism and metabolic dysfunction-associated steatotic liver disease in mice via FXR signaling pathway and gut-liver axis.羽扇豆醇通过 FXR 信号通路和肠-肝轴改善胆汁酸代谢和代谢相关脂肪性肝病。
Biomed Pharmacother. 2024 Aug;177:116942. doi: 10.1016/j.biopha.2024.116942. Epub 2024 Jun 17.
5
Reduces Hepatic Lipogenic Pathways and Increases Intestinal Gluconeogenic Gene Expression in Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD) Mice.降低代谢功能障碍相关脂肪性肝病(MASLD)小鼠肝脏脂肪生成途径并增加肠道糖异生基因表达。
Int J Mol Sci. 2024 Mar 20;25(6):3481. doi: 10.3390/ijms25063481.
6
Disruption of gut barrier integrity and host-microbiome interactions underlie MASLD severity in patients with type-2 diabetes mellitus.肠屏障完整性的破坏和宿主-微生物组的相互作用是 2 型糖尿病患者 MASLD 严重程度的基础。
Gut Microbes. 2024 Jan-Dec;16(1):2304157. doi: 10.1080/19490976.2024.2304157. Epub 2024 Jan 18.
7
High dietary Fructose Drives Metabolic Dysfunction-Associated Steatotic Liver Disease via Activating ubiquitin-specific peptidase 2/11β-hydroxysteroid dehydrogenase type 1 Pathway in Mice.高膳食果糖通过激活泛素特异性肽酶 2/11β-羟类固醇脱氢酶 1 途径导致代谢功能障碍相关脂肪性肝病。
Int J Biol Sci. 2024 Jun 17;20(9):3480-3496. doi: 10.7150/ijbs.97309. eCollection 2024.
8
Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD).打破障碍:肠道内稳态在代谢相关脂肪性肝病(MASLD)中的作用。
Gut Microbes. 2024 Jan-Dec;16(1):2331460. doi: 10.1080/19490976.2024.2331460. Epub 2024 Mar 21.
9
Gut microbiota-NLRP3 inflammasome crosstalk in metabolic dysfunction-associated steatotic liver disease.肠道微生物群-NLRP3 炎性小体在代谢功能障碍相关脂肪性肝病中的相互作用。
Clin Res Hepatol Gastroenterol. 2024 Oct;48(8):102458. doi: 10.1016/j.clinre.2024.102458. Epub 2024 Sep 2.
10
Therapeutic siRNA targeting PLIN2 ameliorates steatosis, inflammation, and fibrosis in steatotic liver disease models.靶向 PLIN2 的治疗性 siRNA 可改善脂肪变性肝病模型中的脂肪变性、炎症和纤维化。
J Lipid Res. 2024 Oct;65(10):100635. doi: 10.1016/j.jlr.2024.100635. Epub 2024 Aug 24.

引用本文的文献

1
Special correlation between diet and MASLD: positive or negative?饮食与代谢相关脂肪性肝病(MASLD)之间的特殊关联:是正相关还是负相关?
Cell Biosci. 2025 Apr 12;15(1):44. doi: 10.1186/s13578-025-01382-1.
2
Effects of Selected Food Additives on the Gut Microbiome and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).所选食品添加剂对肠道微生物群及代谢功能障碍相关脂肪性肝病(MASLD)的影响
Medicina (Kaunas). 2025 Jan 22;61(2):192. doi: 10.3390/medicina61020192.
3
Nutraceutical Potential and Food Safety of Fructose in Soda and Diet Beverages.

本文引用的文献

1
Tauroursodeoxycholic Acid Improves Nonalcoholic Fatty Liver Disease by Regulating Gut Microbiota and Bile Acid Metabolism.牛磺熊去氧胆酸通过调节肠道微生物群和胆汁酸代谢改善非酒精性脂肪性肝病。
J Agric Food Chem. 2024 Sep 11;72(36):20194-20210. doi: 10.1021/acs.jafc.4c04630. Epub 2024 Aug 28.
2
DHA-enriched phosphatidylserine ameliorates cyclophosphamide-induced liver injury via regulating the gut-liver axis.富含二十二碳六烯酸的磷脂酰丝氨酸通过调节肠-肝轴改善环磷酰胺诱导的肝损伤。
Int Immunopharmacol. 2024 Oct 25;140:112895. doi: 10.1016/j.intimp.2024.112895. Epub 2024 Aug 11.
3
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review.
苏打水和无糖饮料中果糖的营养保健潜力与食品安全
Foods. 2025 Feb 14;14(4):648. doi: 10.3390/foods14040648.
非酒精性脂肪性肝病(NAFLD)和非酒精性脂肪性肝炎(NASH)的全球流行病学:系统评价。
Hepatology. 2023 Apr 1;77(4):1335-1347. doi: 10.1097/HEP.0000000000000004. Epub 2023 Jan 3.
4
Eating, diet, and nutrition for the treatment of non-alcoholic fatty liver disease.饮食与营养治疗非酒精性脂肪性肝病。
Clin Mol Hepatol. 2023 Feb;29(Suppl):S244-S260. doi: 10.3350/cmh.2022.0364. Epub 2022 Dec 14.
5
Gut Microbiota Dysbiosis: Triggers, Consequences, Diagnostic and Therapeutic Options.肠道微生物群失调:触发因素、后果、诊断与治疗选择
Microorganisms. 2022 Mar 7;10(3):578. doi: 10.3390/microorganisms10030578.
6
Could gut mycobiome play a role in NAFLD pathogenesis? Insights and therapeutic perspectives.肠道真菌菌群会在非酒精性脂肪性肝病发病机制中发挥作用吗?见解与治疗前景。
Metabol Open. 2022 Mar 14;14:100178. doi: 10.1016/j.metop.2022.100178. eCollection 2022 Jun.
7
The fecal mycobiome in non-alcoholic fatty liver disease.非酒精性脂肪性肝病的粪便真菌组。
J Hepatol. 2022 Apr;76(4):788-799. doi: 10.1016/j.jhep.2021.11.029. Epub 2021 Dec 10.
8
Gut Microbiota and NAFLD: Pathogenetic Mechanisms, Microbiota Signatures, and Therapeutic Interventions.肠道微生物群与非酒精性脂肪性肝病:发病机制、微生物群特征及治疗干预
Microorganisms. 2021 Apr 29;9(5):957. doi: 10.3390/microorganisms9050957.
9
Multiple Parallel Hits Hypothesis in Nonalcoholic Fatty Liver Disease: Revisited After a Decade.非酒精性脂肪性肝病的多重平行打击假说:十年后再审视
Hepatology. 2021 Feb;73(2):833-842. doi: 10.1002/hep.31518. Epub 2021 Feb 6.
10
Analysis of compositions of microbiomes with bias correction.具有偏置校正的微生物组组成分析。
Nat Commun. 2020 Jul 14;11(1):3514. doi: 10.1038/s41467-020-17041-7.